Chee Conley

CIK 00018838041 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001883804

Recent Transactions

26 trades

Sale
Syros Pharmaceuticals, Inc.
Common Stock
2024-11-18$0.20/sh−134,797→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-10-31−17,000→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-10-31+17,000→ 139,504 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2024-10-31$2.09/sh−8,707→ 130,797 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2024-09-11$1.71/sh+50,000→ 122,504 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2024-09-10$1.51/sh+50,000→ 72,504 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2024-04-01$5.12/sh−3,500→ 22,504 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−2,000→ 4,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+11,666→ 26,004 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+2,000→ 14,338 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−11,666→ 23,334 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-12-02+86,000→ 86,000 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-11-01$2.22/sh−6,004→ 12,338 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-10-31−17,000→ 17,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-10-31+17,000→ 18,342 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-04-03$2.58/sh−658→ 1,342 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-03-31+2,000→ 2,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-03-31−2,000→ 6,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-02-16+35,000→ 35,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-10-06+44,500→ 44,500 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-10-06+34,000→ 34,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-10-06+34,000→ 34,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-10-06+44,500→ 44,500 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+80,000→ 80,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-02-15+100,000→ 100,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-09-27+360,000→ 360,000 total

Companies

Syros Pharmaceuticals, Inc.
Chief Commercial Officer

Recent Filings

Address

C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE

CAMBRIDGE, MA, 02140

View on SEC.gov